GC
SGFY

Guggenheim Capital’s Signify Health, Inc. SGFY Stock Holding History

Guggenheim Capital’s Portfolio SGFY Stock Details SGFY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-198,282
Closed -$5.68M – 2043
2022
Q4 		$5.68M Sell
198,282
-24,216
-11% -$699K 0.05% 474
2022
Q3 		$6.49M Buy
222,498
+512
+0.2% +$11.8K 0.06% 405
2022
Q2 		$3.06M Sell
221,986
-7,000
-3% -$98.6K 0.02% 734
2022
Q1 		$4.16M Buy
228,986
+1,990
+0.9% +$28.5K 0.03% 720
2021
Q4 		$3.23M Buy
226,996
+54,883
+32% +$849K 0.02% 858
2021
Q3 		$3.08M Buy
+172,113
New +$4.43M 0.02% 848

Other funds holding SGFY

BHCM
Brevan Howard Capital Management St. Helier, Jersey $11.3B AUM 35.84% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
AW
Avion Wealth The Woodlands, Texas $484M AUM 15.17% 1-Year Est. Return
FCA
FinTrust Capital Advisors Greenville, South Carolina $591M AUM 26.89% 1-Year Est. Return

Guggenheim Capital's SGFY Position: Q1 2023 in Review

Guggenheim Capital sold out of Signify Health, Inc. (SGFY) in Q1 2023, closing a stake of 198,282 shares — an estimated $5.68M sold.

Guggenheim Capital first reported a position in SGFY in Q3 2021 and held it in 6 quarters. The position peaked at $6.49M in Q3 2022. 5 funds tracked by Wall St. Rank hold SGFY as of Q1 2023.

  • Guggenheim Capital reported no remaining Signify Health, Inc. position as of Q1 2023 after selling out during the quarter.
  • Guggenheim Capital sold 198,282 Signify Health, Inc. shares in Q1 2023, an estimated $5.68M.
  • Guggenheim Capital first reported a position in Signify Health, Inc. in Q3 2021 and held it in 6 quarters.
  • Guggenheim Capital's Signify Health, Inc. position peaked at $6.49M in Q3 2022.
  • 5 funds tracked by Wall St. Rank held Signify Health, Inc. as of Q1 2023.

Based on Guggenheim Capital's 13F filing for Q1 2023, filed 11 May 2023.